Show simple item record

dc.contributor.authorSmyth, ECen_US
dc.contributor.authorCunningham, Den_US
dc.date.accessioned2017-07-05T10:55:59Z
dc.date.issued2016-06en_US
dc.identifier.citationThe Lancet. Oncology, 2016, 17 (6), pp. 682 - 683en_US
dc.identifier.issn1470-2045en_US
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/680
dc.identifier.eissn1474-5488en_US
dc.identifier.doi10.1016/s1470-2045(16)30094-8en_US
dc.formatPrint-Electronicen_US
dc.format.extent682 - 683en_US
dc.languageengen_US
dc.language.isoengen_US
dc.rights.urihttp://www.rioxx.net/licenses/all-rights-reserveden_US
dc.titleEncouraging results for PD-1 inhibition in gastric cancer.en_US
dc.typeJournal Article
dcterms.dateAccepted2016-04-15en_US
rioxxterms.versionofrecord10.1016/s1470-2045(16)30094-8en_US
rioxxterms.licenseref.startdate2016-06en_US
rioxxterms.typeJournal Article/Reviewen_US
dc.relation.isPartOfThe Lancet. Oncologyen_US
pubs.issue6en_US
pubs.notesNot knownen_US
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Medicine (RMH Smith Cunningham)
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Medicine (RMH Smith Cunningham)/Medicine (RMH Smith Cunningham) (hon.)
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.volume17en_US
pubs.embargo.termsNot knownen_US
icr.researchteamMedicine (RMH Smith Cunningham)en_US
dc.contributor.icrauthorCunningham, Daviden_US
dc.contributor.icrauthorSmyth, Lizzyen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record